Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases

US6573278B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Joachim Mittendorf · Wuppertal, DE
• Jurgen Dressel · Radevormwald, DE
• Michael Matzke · Wuppertal, DE
• Jörg Keldenich · Wuppertal, DE
• Klaus-Helmut Mohrs · Wuppertal, DE
• Siegfried Raddatz · Hanerau-Hademarschen, DE
• Jürgen Franz · Haan, DE
• Peter Spreyer · Düsseldorf, DE
• Verena Vöhringer · Wuppertal, DE
• Joachim Schuhmacher · Wuppertal, DE
• Michael Harold Rock · Nørresundby, DK
• Ervin Horvath · Leverkusen, DE
• Arno Friedl · Bensberg, DE
• Frank Mauler · Overath, DE
• Jean De Vry · Stolberg, DE
• Reinhard Jork · Haan, DE

Key dates

• Filing date: Jun 11, 2001
• Grant date: Jun 3, 2003
• Expiry date: Jun 11, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2602/10
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to new aryl ether sulphonamides and analogues, processes for their preparation and their use for the treatment of neurodegenerative disorders, in particular for the prophylaxis and treatment of neurodegenerative disorders, in particular for the treatment of cerebral apoplexy and craniocerebral trauma.